Tissue-specific insulator function at H19/Igf2 revealed by deletions at the imprinting control region.
Ideraabdullah FY, Thorvaldsen JL, Myers JA, Bartolomei MS.
Hum Mol Genet. 2014 Dec 1;23(23):6246-59. doi: 10.1093/hmg/ddu344. Epub 2014 Jul 2.
PMID: 24990148
Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.
Fabian CJ, Kimler BF, Donnelly JE, Sullivan DK, Klemp JR, Petroff BK, Phillips TA, Metheny T, Aversman S, Yeh HW, Zalles CM, Mills GB, Hursting SD.
Breast Cancer Res Treat. 2013 Nov;142(1):119-32. doi: 10.1007/s10549-013-2730-8. Epub 2013 Oct 19.
PMID: 24141897
Calorie restriction and cancer prevention: a mechanistic perspective.
Hursting SD, Dunlap SM, Ford NA, Hursting MJ, Lashinger LM.
Cancer Metab. 2013 Mar 7;1(1):10. doi: 10.1186/2049-3002-1-10.
PMID: 24280167 [PubMed]
Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and microRNA expression.
Olivo-Marston SE, Hursting SD, Perkins SN, Schetter A, Khan M, Croce C, Harris CC, Lavigne J.
PLoS One. 2014 Apr 14;9(4):e94765. doi: 10.1371/journal.pone.0094765. eCollection 2014.
PMID: 24732966
Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor-1-dependent manner.
Harvey AE, Lashinger LM, Hays D, Harrison LM, Lewis K, Fischer SM, Hursting SD.
PLoS One. 2014 May 7;9(5):e94151. doi: 10.1371/journal.pone.0094151. eCollection 2014.
PMID: 24804677
NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions.
Bowers LW, Maximo IX, Brenner AJ, Beeram M, Hursting SD, Price RS, Tekmal RR, Jolly CA, deGraffenried LA.
Cancer Res. 2014 Aug 15;74(16):4446-57. doi: 10.1158/0008-5472.CAN-13-3603.
PMID: 25125682
Associations between time spent sitting and cancer-related biomarkers in postmenopausal women: an exploration of effect modifiers.
Paxton RJ, Jung SY, Vitolins MZ, Fenton J, Paskett E, Pollak M, Hays-Grudo J, Hursting SD, Chang S.
Cancer Causes Control. 2014 Nov;25(11):1427-37. doi: 10.1007/s10552-014-0434-y. Epub 2014 Sep 20.
PMID: 25238978
Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with Doxorubicin.
Niu M, Naguib YW, Aldayel AM, Shi YC, Hursting SD, Hersh MA, Cui Z.
Mol Pharm. 2014 Dec 1;11(12):4425-36. doi: 10.1021/mp500565q. Epub 2014 Oct 27.
PMID: 25314115